Publicaciones en las que colabora con EDUARDO GARCIA-GRANERO XIMENEZ (22)

2023

  1. Selective neoadyuvant therapy in locally advanced rectal cancer: For whom and with what aim?

    Cirugia Espanola

  2. The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer

    Colorectal Disease, Vol. 25, Núm. 6, pp. 1135-1143

2022

  1. Cáncer de recto

    Cirugía AEC: Manual de la Asociación Española de Cirujanos (Editorial Médica Panamericana), pp. 603-624

2021

  1. Peritoneal invasion and metachronous peritoneal metastases after colon cancer surgery: The role of homogeneous, reliable assessment and confounders

    European Journal of Surgical Oncology

  2. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 1, pp. 29-42

  3. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project

    European Journal of Surgical Oncology, Vol. 47, Núm. 2, pp. 276-284

2020

  1. Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 63-72

2019

  1. Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer

    Diseases of the Colon and Rectum, Vol. 62, Núm. 6, pp. 684-693

2018

  1. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2

2017

  1. Stents metálicos autoexpandibles como puente a la cirugía en el tratamiento del cáncer de colon izquierdo en oclusión. Análisis coste-beneficio y resultados oncológicos

    Cirugia Espanola, Vol. 95, Núm. 3, pp. 143-151

2015

  1. Selective approach for upper rectal cancer treatment: Total mesorectal excision and preoperative chemoradiation are seldom necessary

    Diseases of the Colon and Rectum, Vol. 58, Núm. 6, pp. 556-565

2012

  1. Pathological evaluation of mesocolic resection quality and ex vivo methylene blue injection: What is the impact on lymph node harvest after colon resection for cancer?

    Diseases of the Colon and Rectum, Vol. 55, Núm. 2, pp. 197-204

  2. T4a and T4b Colorectal cancer: What does this mean nowadays

    Diseases of the Colon and Rectum

2011

  1. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer

    Cancer, Vol. 117, Núm. 14, pp. 3118-3125

  2. Prognostic implications of circumferential location of distal rectal cancer

    Colorectal Disease, Vol. 13, Núm. 6, pp. 650-657

2009

  1. Macroscopic assessment of mesorectal excision in rectal cancer: A useful tool for improving quality control in a multidisciplinary team

    Cancer, Vol. 115, Núm. 15, pp. 3400-3411

  2. Prognostic heterogeneity of endosonographic T3 rectal cancer

    Diseases of the Colon and Rectum, Vol. 52, Núm. 4, pp. 685-691

2008

  1. Progress in the multidisciplinary treatment of gastrointestinal cancer and the impact on clinical practice: Perioperative management of rectal cancer

    Annals of Oncology

2007

  1. Integrative decisions in rectal cancer

    Annals of Oncology

2006

  1. A multimodality approach to localized rectal cancer

    Annals of Oncology, Vol. 17, Núm. SUPPL. 10